Current List of Clinical Trials

Clinical Research Department

Jeanine Secor, RN, BSN, CCRP Nicole Fitzpatrick, MPH, RN Marinna Agnelli, BS
Clinical Research Director Clinical Research Nurse Research Data Analyst
(561) 263-5791 (561) 263-5768 (561) 263-3689


Development of patient-derived xenograft tumor models for lung and breast cancers.

Biomarker Development for Lung Cancer: Collection of Serum from Persons Undergoing Diagnostic Lung Biopsy

Procurement of Human Biospecimens for Research

Research Supplied: None

A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma

Research Supplied: Ipilimumab

A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or without Everolimus (Affinitor) for Therapy of Metastatic Malignant Melanoma


Date: April 1, 2014
Hyperbaric Oxygen (HBO) Therapy for Traumatic Brain Injury

Acquisition of Existing Paraffin Blocks and Existing Non-Identifying Data for Future Research

Collection of Human Bio-specimens for Biomarker Analysis: Known & Future Unknown Medical Research

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer.

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer. e3 Breast Cancer Study – evaluating everolimus with endocrine therapy